Prospective, Randomized, Multicenter Trial of Peroneal Electrical Transcutaneous NeuroModulation versus Solifenacin in Treatment of Naïve Patients with Overactive Bladder.

Jan KrhutMichal RejchrtMartin SlovakRoman V DvorakLukas PeterBertil F M BlokPeter Zvara

Published in: The Journal of urology (2022)

Peroneal eTNM is a safe and effective method for OAB treatment associated with significantly lower incidence of treatment-related adverse events compared to solifenacin and considerably better benefit-risk profile.

Keyphrases

clinical trial
randomized controlled trial
combination therapy
phase ii
open label
replacement therapy
smoking cessation
breast cancer risk